Nanostructured
Lipid Carrier
|
|
 |
|
|
PharmaSol
- the solubility people -
|
Situation analysis:
About 40% of drugs in the pipeline and 60% of drugs coming directly from synthesis or high throughput screening
are classified as poorly soluble. Consequently, they have bioavailability and/or delivery problems.
The mission:
PharmaSol provides solutions for overcoming the solubility and related bioavailability problems of poorly soluble
compounds. PharmaSol solutions are simple, cost-effective, regulatorily acceptable and cover lab to industrial
scale production. Focus areas are oral, dermal and intravenous delivery.
|
Nanocrystals
|
PharmaSol's expertise:
Pharmaceutical solutions to increase the Solubility of poorly soluble compounds.
|
|
